Meitar represented Enzymotec Ltd., a developer of lipid-based products and solutions for the nutritional and healthcare markets, in its initial public offering on NASDAQ raising approximately $70M (including exercise at closing of the underwriters’ overallotment option in full). Bank of America Merrill Lynch and Jefferies LLC acted as joint book-running managers for the offering.
Meitar represented Stratasys Ltd. (SSYS) in a public offering of ordinary shares for approximately $481M on NASDAQ with JP Morgan as sole-book-runner and Piper Jaffray, Morgan Stanley, Bank of America Merrill Lynch and Needham as co-managers.
Our firm represented ROTH Capital partners in the $20 million follow on offering by Attunity Ltd. on NASDAQ.
Our firm represented Cimatron (NASDAQ:CIMT), a leading global provider of integrated CAD/CAM software solutions for the tool making and manufacturing industries, in its $15.7 million secondary and $6.2 million follow-on public offerings of Ordinary Shares on NASDAQ.
Our firm represented Needham & Company and Oppenheimer & Co in the $32 million ordinary shares of Ceragon Networks on NASDAQ.
Meitar represented Sapiens (TASE and NASDAQ: SPNS), a leading global provider of software solutions for the insurance industry, in its $40 million public offering.
Our firm represented Barclays Capital Inc. and Citigroup Global Markets Inc. in the $1.4 billion global notes offering by Israel Electric Corporation.
